Loading stock data…
Baxter International Inc (BAX)
$22.02-0.02 (-0.09%)
Market ClosedLast close Jun 29
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Baxter International Inc. in the Healthcare sector is trading at $22.02 with a market capitalization of $10.8B. Wall Street consensus targets $21.54 (12 analysts), implying a -2.2% move over the next 12 months. The stock is currently 31% below its 52-week high of $31.76, remaining 12.5% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.70B↓ | $2.97B↑ | $2.83B↑ | $2.81B↑ | $2.63B |
| Gross Profit | $891.00M↑ | $577.00M↓ | $950.00M↓ | $991.00M↑ | $861.00M |
| Operating Income | $66.00M↑ | -$244.00M↓ | $172.00M↓ | $191.00M↑ | $58.00M |
| Net Income | -$15.00M↑ | -$1.13B↓ | -$46.00M↓ | $91.00M↓ | $126.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$10.82B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.86%
ROE
Average efficiency. Growth may require heavy reinvestment.
-18.17%
Volume
Today's trading volume
5.72M
Recent News
Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform
BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.
Is Baxter International Stock Underperforming the S&P 500?
Due to Baxter International's underperformance relative to the S&P 500 over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.
Reasons to Retain Baxter International Stock in Your Portfolio for Now
BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.
Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value Warranted
Wondering whether Baxter International at US$20.86 is a bargain or a value trap? This article breaks down what the current share price might be telling you about the stock. The stock has risen 7.6% over the past week and 20.6% over the past month, yet is still down 7.0% year to date and has declined 31.3% over the last year. This raises questions about how the market now views its risk and potential. Recent coverage has focused on Baxter International's position within the medical equipment...
Baxter International (BAX) Stock Valuation Check After Recent Double Digit Gains And Ongoing Turnaround Plans
Baxter International (BAX) has attracted fresh attention after recent trading, with the stock showing double digit returns over the past month and past 3 months. This performance is prompting investors to reassess its current valuation. See our latest analysis for Baxter International. The recent move takes Baxter International's share price to US$20.86, with share price returns of 20.58% over 30 days and 22.13% over 90 days, while the 1 year total shareholder return has declined 31.29%. This...